Related Experiment Video

Updated: Jul 7, 2026

In vivo Macrophage Imaging Using MR Targeted Contrast Agent for Longitudinal Evaluation of Septic Arthritis
07:15

In vivo Macrophage Imaging Using MR Targeted Contrast Agent for Longitudinal Evaluation of Septic Arthritis

Published on: October 20, 2013

Macrophage activation syndrome: a frequent but under-diagnosed complication associated with rheumatic diseases

Antonio G Tristano1

  • 1Department of Internal Medicine, Dr. Domingo Luciani Hospital, Caracas, Venezuela. mjtristano@cantv.net

Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|February 28, 2008
PubMed

Insights

Macrophage activation syndrome (MAS), a severe complication in rheumatic diseases like juvenile rheumatoid arthritis, involves immune system dysregulation. Current treatments for MAS are varied and not standardized, highlighting the need for further research.

Area of Science:

  • Rheumatology
  • Immunology
  • Pediatrics

Background:

  • Macrophage activation syndrome (MAS), also known as hemophagocytic syndrome, is a critical complication of chronic rheumatic diseases, particularly systemic-onset juvenile rheumatoid arthritis (JRA).
  • The exact cause of MAS remains unknown, but it is hypothesized to stem from a dysregulation in macrophage-lymphocyte interactions, leading to elevated cytokine levels and a severe systemic inflammatory response.

Discussion:

  • MAS presents with acute febrile illness, hepatosplenomegaly, lymphadenopathy, bleeding, pancytopenia, and potential organ involvement (CNS, cardiac, renal).
  • Diagnosis relies on recognizing these clinical signs and laboratory abnormalities, although specific diagnostic criteria can be challenging to meet.

Key Insights:

  • The pathogenesis involves an overactive immune response characterized by cytokine storm, driven by dysregulated immune cell interactions.
  • Clinical manifestations are systemic and severe, affecting multiple organ systems and requiring prompt recognition.

Outlook:

  • Treatment strategies for MAS in rheumatic disease patients are diverse and include corticosteroids, cyclosporine, cyclophosphamide, etoposide, and IVIG, but remain non-standardized.
  • Further research is essential to elucidate MAS pathogenesis, establish standardized diagnostic criteria, and optimize treatment protocols for better patient outcomes.

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...